Table 2.
T2D and CHD in meta-analyses
|
|||||
---|---|---|---|---|---|
p-value cut point | # of SNPs in total | # of SNPs CHD/T2D consistent | % of SNPs CHD/T2D consistent | adjusted −log10(p-value)* | |
T2D | CHD | ||||
(0, 5×10−8] | – | 1,260 | 959 | 76.11% | 76.966 |
– | (0, 5×10−8] | 595 | 287 | 48.24% | 0.062 |
(0.5, 1] | (0.5, 1] | 1,874,138 | 948,292 | 50.60% | – |
(5×10−8, 0.05] | (5×10−8, 0.05] | 36,242 | 29,634 | 81.77% | 3319.168 |
P-value values from the binomial sign test were reported. The probability used to estimate the p-values in the binomial sign test is the percentage highlighted in red.